IL17A and COVID-19: The utility of compound scores, particularly a weighted sum of IL-6, MCP, CXCL, IL-6, IL10, IL-17A, and IL-1β, were particularly stronger in predicting disease severity, reinforcing the potential of a multifaceted biomarker approach in managing COVID-19.